Literature DB >> 21776165

Nature and course of disability in schizophrenia.

R Thara1, S Rajkumar.   

Abstract

Sixty eight Feighner positive schizophrenic patients were followed up prospectively for a period of six years using standardized instruments. Disability was assessed in this sample using the Schedule for the Assessment of Psychiatric Disability at the end of 4, 5 and 6 years of follow up. It was found that the three year course of disability tended to be stable and fluctuations were minimal. Disability did not seem to be related to relapses. The implications of these findings in planning intervention programs for chronic schizophrenic patients are discussed.

Entities:  

Year:  1993        PMID: 21776165      PMCID: PMC2972565     

Source DB:  PubMed          Journal:  Indian J Psychiatry        ISSN: 0019-5545            Impact factor:   1.759


  1 in total

1.  Prognosis and outcome in a cohort of patients with non-affective functional psychosis.

Authors:  R Giel; D Wiersma; P A de Jong; C Slooff
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1984
  1 in total
  5 in total

1.  Indian Psychiatry and Indian Journal of Psychiatry - A journey.

Authors:  T S Sathyanarayana Rao; G Swaminath; G Prasad Rao
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

2.  An overview of Indian research in schizophrenia.

Authors:  Parmanand Kulhara; Ruchita Shah; K R Aarya
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

3.  Women psychiatrists in India: A reflection of their contributions.

Authors:  Mamta Sood; Rakesh K Chadda
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

4.  Disabilities research in India.

Authors:  H Chandrashekar; C Naveen Kumar; N R Prashanth; P Kasthuri
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

5.  Instrumental Activities of Daily Living Dysfunction among People with Schizophrenia.

Authors:  Reema Samuel; Elizabeth Thomas; K S Jacob
Journal:  Indian J Psychol Med       Date:  2018 Mar-Apr
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.